Synopsis
Amorolfineis a morpholine antifungal drug,can inhibit Δ17-sterol reductase and cholesterol Δ-isomerase,
The global Amorolfine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Amorolfine in various end use industries. The expanding demands from the Injection Product, Table Product and Others,, are propelling Amorolfine market. Purity:≤99%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Purity:>99% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Amorolfine market, driven by demand from China, the second largest economy with some signs of stabilising, the Amorolfine market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Amorolfine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Amorolfine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Amorolfine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Amorolfine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Amorolfine covered in this report include Nishchem International, Canagen Pharmaceuticals Inc, Allastir and Sun Pharma, etc.
The global Amorolfine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Nishchem International
Canagen Pharmaceuticals Inc
Allastir
Sun Pharma
Global Amorolfine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Amorolfine market, Segment by Type:
Purity:≤99%
Purity:>99%
Global Amorolfine market, by Application
Injection Product
Table Product
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Amorolfine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Amorolfine
1.1 Amorolfine Market Overview
1.1.1 Amorolfine Product Scope
1.1.2 Amorolfine Market Status and Outlook
1.2 Global Amorolfine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Amorolfine Market Size by Region (2018-2029)
1.4 Global Amorolfine Historic Market Size by Region (2018-2023)
1.5 Global Amorolfine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Amorolfine Market Size (2018-2029)
1.6.1 North America Amorolfine Market Size (2018-2029)
1.6.2 Europe Amorolfine Market Size (2018-2029)
1.6.3 Asia-Pacific Amorolfine Market Size (2018-2029)
1.6.4 Latin America Amorolfine Market Size (2018-2029)
1.6.5 Middle East & Africa Amorolfine Market Size (2018-2029)
2 Amorolfine Market by Type
2.1 Introduction
2.1.1 Purity:≤99%
2.1.2 Purity:>99%
2.2 Global Amorolfine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Amorolfine Historic Market Size by Type (2018-2023)
2.2.2 Global Amorolfine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Amorolfine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Amorolfine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Amorolfine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Amorolfine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Amorolfine Revenue Breakdown by Type (2018-2029)
3 Amorolfine Market Overview by Application
3.1 Introduction
3.1.1 Injection Product
3.1.2 Table Product
3.1.3 Others
3.2 Global Amorolfine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Amorolfine Historic Market Size by Application (2018-2023)
3.2.2 Global Amorolfine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Amorolfine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Amorolfine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Amorolfine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Amorolfine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Amorolfine Revenue Breakdown by Application (2018-2029)
4 Amorolfine Competition Analysis by Players
4.1 Global Amorolfine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amorolfine as of 2022)
4.3 Date of Key Players Enter into Amorolfine Market
4.4 Global Top Players Amorolfine Headquarters and Area Served
4.5 Key Players Amorolfine Product Solution and Service
4.6 Competitive Status
4.6.1 Amorolfine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Nishchem International
5.1.1 Nishchem International Profile
5.1.2 Nishchem International Main Business
5.1.3 Nishchem International Amorolfine Products, Services and Solutions
5.1.4 Nishchem International Amorolfine Revenue (US$ Million) & (2018-2023)
5.1.5 Nishchem International Recent Developments
5.2 Canagen Pharmaceuticals Inc
5.2.1 Canagen Pharmaceuticals Inc Profile
5.2.2 Canagen Pharmaceuticals Inc Main Business
5.2.3 Canagen Pharmaceuticals Inc Amorolfine Products, Services and Solutions
5.2.4 Canagen Pharmaceuticals Inc Amorolfine Revenue (US$ Million) & (2018-2023)
5.2.5 Canagen Pharmaceuticals Inc Recent Developments
5.3 Allastir
5.3.1 Allastir Profile
5.3.2 Allastir Main Business
5.3.3 Allastir Amorolfine Products, Services and Solutions
5.3.4 Allastir Amorolfine Revenue (US$ Million) & (2018-2023)
5.3.5 Sun Pharma Recent Developments
5.4 Sun Pharma
5.4.1 Sun Pharma Profile
5.4.2 Sun Pharma Main Business
5.4.3 Sun Pharma Amorolfine Products, Services and Solutions
5.4.4 Sun Pharma Amorolfine Revenue (US$ Million) & (2018-2023)
5.4.5 Sun Pharma Recent Developments
6 North America
6.1 North America Amorolfine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Amorolfine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Amorolfine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Amorolfine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Amorolfine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Amorolfine Market Dynamics
11.1 Amorolfine Industry Trends
11.2 Amorolfine Market Drivers
11.3 Amorolfine Market Challenges
11.4 Amorolfine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List